AbbVie Inc. (ABBV) vs Constellation Brands, Inc. (STZ)
A side-by-side comparison of AbbVie Inc. and Constellation Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; STZ is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$261.70HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT
STZ
Constellation Brands, Inc.
$125.00Consumer DefensiveDelayed quote: Sep 14, 2026, 4:00 PM EDT
Total return — ABBV vs STZ
growth of $100 · dividends reinvested · last 10yABBV +512.1% (+19.9%/yr)STZ -13.7% (-1.5%/yr)ABBV compounded faster over this window
Log scale — wide-divergence pair
ABBV STZ
ABBV vs STZ: by the numbers
- •ABBV is the larger company ($462.37B vs $21.35B market cap).
- •STZ trades at the lower trailing earnings multiple (11.93 vs 73.73 P/E), one valuation lens rather than an overall verdict.
- •STZ converts more revenue to profit (20.14% vs 9.81% net margin).
- •ABBV grew revenue faster over the past five years (3.69% vs 0.86% CAGR).
- •STZ pays the higher dividend yield (3.35% vs 2.66%).
Metrics side by side
Valuation
| Metric | ABBV | STZ |
|---|---|---|
| P/E ratio | 73.73 | 11.93 |
| Forward P/E | 18.63 | 10.59 |
| P/S ratio | 7.18 | 2.36 |
| P/B ratio | N/A | 2.59 |
| EV / EBITDA | 19.65 | 9.57 |
| FCF yield | 3.92% | 8.59% |
Profitability
| Metric | ABBV | STZ |
|---|---|---|
| Gross margin | 71.48% | 52.62% |
| Operating margin | 29.32% | 32.14% |
| Net margin | 9.81% | 20.14% |
| ROE | N/A | 22.10% |
| ROIC | 13.46% | 10.85% |
Dividends
| Metric | ABBV | STZ |
|---|---|---|
| Dividend yield | 2.66% | 3.35% |
| Payout ratio | 192.43% | 39.12% |
Growth (annualized)
| Metric | ABBV | STZ |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 0.86% |
| EPS CAGR (5Y) | -2.79% | -1.59% |
| FCF CAGR (5Y) | 0.11% | -1.73% |
| Total return CAGR (5Y) | 23.70% | -8.87% |
Frequently asked
- Which has the lower trailing P/E, ABBV or STZ?
- STZ has the lower trailing P/E: ABBV trades at 73.73 and STZ at 11.93. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or STZ?
- Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus STZ at 0.86%.
- Does ABBV or STZ pay a bigger dividend?
- ABBV yields 2.66% and STZ yields 3.35% based on trailing dividends and the latest price.
- Is ABBV or STZ more profitable?
- STZ runs the higher net margin — ABBV at 9.81% versus STZ at 20.14%.
- How have ABBV and STZ total returns compared?
- Over the past 10 years, ABBV delivered 19.85% and STZ delivered -1.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioConstellation Brands P/E ratioAbbVie dividend yieldConstellation Brands dividend yieldAbbVie ROEConstellation Brands ROEAbbVie operating marginConstellation Brands operating marginAbbVie revenue growthConstellation Brands revenue growthAbbVie free cash flowConstellation Brands free cash flow
AbbVie & Constellation Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.